Palantir CEO’s Fentanyl Remarks Spark Controversy
During a recent earnings call, Palantir CEO Alex Karp voiced his support for the Trump administration’s anti-drug campaign, specifically addressing the ongoing fentanyl crisis. His remarks, however, have ignited controversy due to the way he framed the issue. The discussion centered on the current fentanyl interdiction efforts and the perceived opposition to them.
Karp’s Controversial Statement
Karp’s statement, as reported by Fox Business, suggested that the response to the fentanyl crisis would be different
About the Author
